Institut Curie, Pierre Fabre partner to develop cancer immunotherapies

The Institut Curie (Paris, France) and the Laboratoires Pierre Fabre S.A. (Castres, France) entered a renwable, one-year partnership to develop cancer immunotherapies against novel targets using the i...